Gerry A. DeBiasi

Gerry joined Kidd & Company in 2001 and has been involved in several of the firm’s investments, including Chatham Technologies, MedSource Technologies, Empower Health, iPacesetters, Reladyne, Logistyx Technologies (which was named Technology Deal of the year by ACG), and most recently Brand Holdings / Dr. Emil Nutrition.
He divides his time between the identification, evaluation and closing of new investment opportunities and the oversight of existing portfolio companies, with a particular focus on multi-company acquisitions/integration strategies.
He joined KCO from Chatham Technologies, where he served as SVP of Business Development and was instrumental in driving revenue growth from $153 MM to over $600 MM over a three-year period.
Previously Gerry was a strategy consultant with The Monitor Company and also worked at Fidelity Investments and The Federal Reserve Board of Governors, in addition to co-founding a specialty publishing company.
Gerry received a BA in Economics, summa cum laude and Phi Beta Kappa, from Dartmouth College and an MBA from Harvard Business School, earning honors recognition in the process.
He is also a member of the Family Office Committee of ACG’s Boston Chapter.